Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abate B. Shewaye"'
Autor:
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha, Hailemichael Desalegn, Chris Kassianides, Leolin Katsidzira, Anna Kramvis, Philip Lam, Olufunmilayo A Lesi, Eileen A Micah, Emmanuel Musabeyezu, Gibril Ndow, Chidi V Nnabuchi, Ponsiano Ocama, Edith Okeke, John Rwegasha, Abate B Shewaye, Fatuma F Some, Christian Tzeuton, Mark W Sonderup
Publikováno v:
The Lancet Gastroenterology & Hepatology. 7:1036-1048
Hepatocellular carcinoma is a leading public health concern in sub-Saharan Africa, and it is most prevalent in young adults (median 45 years [IQR 35-57]). Overall, outcomes are poor, with a median survival of 2·5 months after presentation. Major ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a47311e2643dae8c5bbadc3642d7d7cf
https://doi.org/10.1016/s2468-1253(22)00041-3
https://doi.org/10.1016/s2468-1253(22)00041-3
Autor:
Aggrey Ambali, Olufunmilayo A. Lesi, Yaw Asante Awuku, Margareth Ndomondo-Sigonda, Charles A Onyekwere, C Wendy Spearman, Abdelmounem Abdo, Chris Kassianides, Abate B Shewaye, John Rwegasha, Mark W. Sonderup
Publikováno v:
The Lancet Gastroenterology & Hepatology. 6:1047-1056
Sub-Saharan Africa, which has a population of more than 1 billion people, carries 24% of the global burden of disease and spends the least on health care of any region, relying heavily on international development assistance to deliver health care fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7af56ddeeff52c13a7cb57dbddc3da
https://doi.org/10.1016/s2468-1253(21)00296-x
https://doi.org/10.1016/s2468-1253(21)00296-x
Autor:
Mark W. Sonderup, Olufunmilayo A. Lesi, C Wendy Spearman, Chris Kassianides, Lina Cunha, Christian Tzeuton, John Rwegasha, Papa Saliou Mbaye, Emmanuel Musabeyezu, Betty S. Apica, Geoffrey Dusheiko, Mary Afihene, Reidwaan Ally, Marie-Jeanne Lohouès-Kouacou, Phillip Lam, Yaw Asante Awuku, Neliswa Gogela, Olesegun Ojo, Betty Musau, Abate B. Shewaye, Barbara Scholz
Publikováno v:
The Lancet Gastroenterology & Hepatology. 2:910-919
In 2016, WHO adopted a strategy for the elimination of viral hepatitis by 2030. Africa, and more specifically, sub-Saharan Africa, carries a substantial portion of the global burden of viral hepatitis, especially chronic hepatitis B and hepatitis C v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f110859266a57f77bdfc5c227ffb5d5c
https://doi.org/10.1016/s2468-1253(17)30249-2
https://doi.org/10.1016/s2468-1253(17)30249-2
Autor:
Philip Lam, Reidwaan Ally, Chris Kassianides, John Rwegasha, Olufunmilayo A. Lesi, Emmanuel Musabeyezu, Christian Tzeuton, Mark W. Sonderup, Michael C. Kew, Neliswa Gogela, Geoffrey Dusheiko, Yaw Asante Awuku, Lina Cunha, Betty Musau, Abate B. Shewaye, Barbara Scholz, O S Ojo, Papa Saliou Mbaye, C Wendy Spearman, Marie Jeanne Lohouès-Kouacou, Betty S. Apica, Mary Afihene
Publikováno v:
The Lancet Gastroenterology & Hepatology. 2:900-909
The WHO global health sector strategy on viral hepatitis, created in May, 2016, aims to achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in mortality due to hepatitis B and C by 2030. Hepatitis B virus (HBV) is en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aac53524c08f578daedc126d7246b91
https://doi.org/10.1016/s2468-1253(17)30295-9
https://doi.org/10.1016/s2468-1253(17)30295-9